Skip to main content
. 2022 Feb 19;27(3):236–243. doi: 10.1093/oncolo/oyab083

Figure 4.

Figure 4.

Subgroup analysis: COVID-19 outcomes in the ICI-treated cohort, stratified by receipt of chemotherapy. (A) COVID-19 mortality outcomes in subgroups treated with ICI only or ICI plus chemotherapy, expressed as percentages of patients affected in each subgroup. (B) Kaplan-Meier plot comparing survival after COVID-19 diagnosis in subgroups treated with ICI only and ICI plus chemotherapy.